← Back to headlines
Denali Therapeutics Reports Q4 Earnings In-Line with Estimates
Denali Therapeutics announced its latest financial results, reporting a GAAP EPS of -$0.73, which was in-line with analyst estimates.
26 Feb, 22:06 — 26 Feb, 22:06
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Ellington Financial Targets Portfolio Growth and Liability Optimization
14m ago
Major Social Security change coming in March 2026; what retirees need to know
30m ago
CAG Study Finds GST Boosted State Revenues
33m ago
IRS tax refund 2026: Why some refunds will get delayed under PATH Act; check February schedule
34m ago